List of Studies ( Metabolite:PE 39:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004167 | AN006917 | Targeted Lipidomic Profiling of STBD1 Knockdown in Clear Cell Renal Carcinoma Cells | Renal cancer cells | Human | Cancer | The Affiliated Cancer Hospital of Zhengzhou University | LC-MS |
| ST003565 | AN005857 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003179 | AN005221 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003160 | AN005184 | New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002926 | AN004798 | Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST002522 | AN004155 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST002107 | AN003446 | Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) | Blood | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001292 | AN002150 | Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. | Kidney | Mouse | Diabetes | University of Michigan | LC-MS |
| ST001127 | AN001852 | Lipid profiling of caecal samples from GF mice colonized with B. thetaiotaomicron WT or the ΔSPT mutants (part III) | Cecum | Mouse | Irritable bowel syndrome | Broad Institute of MIT and Harvard | LC-MS |
| ST001125 | AN001850 | WT and ΔSPT cultures of B. thetaiotaomicron and B. ovatus grown BHI liquid media (part I) | Bacterial cells | Bacteroides ovatus | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST001125 | AN001850 | WT and ΔSPT cultures of B. thetaiotaomicron and B. ovatus grown BHI liquid media (part I) | Bacterial cells | Bacteroides thetaiotaomicron | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000780 | AN001234 | High fat diet and sciatic nerves functions | Blood | Mouse | Neuropathy | University of Michigan | LC-MS |
| ST000778 | AN001230 | Rat Colon Study effect of Effect of fish oil on azoxymethane (AOM) | Colon | Rat | University of Michigan | LC-MS | |
| ST000776 | AN001226 | Fish Oil distal colon from rats | Colon | Rat | University of Michigan | LC-MS | |
| ST000685 | AN001056 | Lipidomics analysis for human liver cell lines | Cultured cells | Human | University of Michigan | LC-MS | |
| ST000679 | AN001044 | Functional genomics study on Non Alcoholic fatty liver disease (NAFLD) - part II | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000676 | AN001038 | Effect of high fat diet and streptozotocin treatment on neuropathy | Blood | Mouse | Neuropathy | University of Michigan | LC-MS |
| ST000672 | AN001030 | Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison (part II) | Blood | Mouse | Diabetes | University of Michigan | LC-MS |
| ST000667 | AN001020 | Diabetic Microvascular Plasma/Tissue Lipidomics- Comparison | Blood | Mouse | Diabetes | University of Michigan | LC-MS |
| ST000665 | AN001016 | Nonalcoholic fatty liver disease (NAFLD) Studies | Cultured cells | Human | Fatty liver disease | University of Michigan | LC-MS |
| ST000662 | AN001010 | Lipidomics of hormone-sensitive lipase variants | Adipose tissue | Human | University of Michigan | LC-MS |
